EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C19H17N3O2 |
| Net Charge | 0 |
| Average Mass | 319.364 |
| Monoisotopic Mass | 319.13208 |
| SMILES | CN1C(=O)c2ccccc2NC(=O)[C@@H]1Cc1cnc2ccccc12 |
| InChI | InChI=1S/C19H17N3O2/c1-22-17(10-12-11-20-15-8-4-2-6-13(12)15)18(23)21-16-9-5-3-7-14(16)19(22)24/h2-9,11,17,20H,10H2,1H3,(H,21,23)/t17-/m0/s1 |
| InChIKey | QYBGEUDXQJVALS-KRWDZBQOSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| [Malbranchea flavorosea (ncbitaxon:465703) | - | PubMed (30018423) |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (S)-3,4-dihydro-3-(1H-indol-3-ylmethyl)-4-methyl-1H-1,4-benzodiazepine-2,5-dione (CHEBI:227037) is a benzodiazepine (CHEBI:22720) |
| IUPAC Name |
|---|
| (3S)-3-(1H-indol-3-ylmethyl)-4-methyl-1,3-dihydro-1,4-benzodiazepine-2,5-dione |
| Manual Xrefs | Databases |
|---|---|
| 78438859 | ChemSpider |